Microbot Medical Inc. financial data

Symbol
MBOT on Nasdaq
Location
25 Recreation Park Dr Suite 108, Hingham, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 880 % +125%
Debt-to-equity 12.9 % -60.8%
Return On Equity -76.3 % +56%
Return On Assets -67.5 % +48.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 45.5M shares +176%
Common Stock, Shares, Outstanding 38M shares +138%
Entity Public Float 15.9M USD -58.3%
Common Stock, Value, Issued 380K USD +136%
Weighted Average Number of Shares Outstanding, Basic 36.5M shares +146%
Weighted Average Number of Shares Outstanding, Diluted 36.5M shares +146%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 7.61M USD +42.9%
General and Administrative Expense 5.86M USD +40.2%
Operating Income (Loss) -13.5M USD -41.7%
Net Income (Loss) Attributable to Parent -12.7M USD -21.8%
Earnings Per Share, Basic 0 USD/shares +26.9%
Earnings Per Share, Diluted 0 USD/shares +26.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.08M USD +65.6%
Marketable Securities, Current 28.6M USD +615%
Cash, Cash Equivalents, and Short-term Investments 32.7M USD +406%
Other Assets, Current 1.34M USD
Assets, Current 32.9M USD +361%
Property, Plant and Equipment, Net 75K USD -38.5%
Operating Lease, Right-of-Use Asset 165K USD -5.17%
Assets 33.1M USD +346%
Accounts Payable, Current 503K USD +183%
Employee-related Liabilities, Current 1.41M USD +94.3%
Accrued Liabilities, Current 2.12M USD +102%
Liabilities, Current 2.73M USD +103%
Operating Lease, Liability, Noncurrent 47K USD +23.7%
Liabilities 2.77M USD +101%
Retained Earnings (Accumulated Deficit) -97M USD -15.1%
Stockholders' Equity Attributable to Parent 30.4M USD +401%
Liabilities and Equity 33.1M USD +346%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.87M USD -18.8%
Net Cash Provided by (Used in) Financing Activities 27.8M USD +1060%
Net Cash Provided by (Used in) Investing Activities -24.8M USD -1834%
Common Stock, Shares Authorized 120M shares +100%
Common Stock, Shares, Issued 38M shares +138%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 102K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 4.14M USD +64.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 40K USD +14.3%
Deferred Tax Assets, Valuation Allowance 118M USD +2.03%
Deferred Tax Assets, Gross 118M USD +1.75%
Operating Lease, Liability 111K USD -51.9%
Payments to Acquire Property, Plant, and Equipment 13K USD -7.14%
Lessee, Operating Lease, Liability, to be Paid 117K USD -57.8%
Property, Plant and Equipment, Gross 664K USD +3.91%
Operating Lease, Liability, Current 102K USD -7.27%
Lessee, Operating Lease, Liability, to be Paid, Year Two 42K USD -12.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 75K USD -63.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6K USD -87.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 21K USD +950%
Deferred Tax Assets, Operating Loss Carryforwards 118M USD +2.19%
Preferred Stock, Shares Authorized 1M shares
Operating Lease, Payments 75K USD -19.4%
Depreciation, Depletion and Amortization 15K USD -46.4%
Deferred Tax Assets, Net of Valuation Allowance 30K USD -91.6%